Skip to main content
Top
Published in: Infectious Agents and Cancer 1/2015

Open Access 01-12-2015 | Research Article

Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria

Authors: Mohammed Mohammed Manga, Adeola Fowotade, Yusuf Mohammed Abdullahi, Aliyu Usman El-nafaty, Danladi Bojude Adamu, Hamidu Umar Pindiga, Rasheed Ajani Bakare, Abimbola Olu Osoba

Published in: Infectious Agents and Cancer | Issue 1/2015

Login to get access

Abstract

Background

Sub-Saharan countries including Nigeria have the highest burden of Human Papillomavirus (HPV) infection in the world. Most studies on HPV surveillance in Nigeria were done in the southern part of the country. Geographical and socio-cultural diversity of Nigeria makes these data unlikely to be universally representative for the entire country. Northern Nigeria especially the North-East carries a higher prevalence of cervical cancer and many of its risk factors. The region may be harbouring a higher prevalence of HPV infection with a possibility of different genotypic distribution. This study was carried out to determine the burden and confirm the predominant HPV genotypes among women presenting for cervical cancer screening at the Federal Teaching Hospital Gombe (FTHG), North-eastern, Nigeria.

Methods

The study was an observational hospital based cross sectional study among women who presented for cervical cancer screening in FTHG. A total of 209 consenting women were tested for cervical HPV infection using PCR. DNA sequencing was carried out on positive samples to determine the prevalent HPV genotypes.

Results

The prevalence of cervical HPV infection among the participants with mean age of 39.6 ± 10.4 years was 48.1 %. The five most predominant genotypes were 18, 16, 33, 31 and 35, with prevalence of 44.7 %, 13.2 %, 7.9 %, 5.3 % and 5.3 % respectively. Other genotypes observed were 38, 45, 56, 58, 82 and KC5. Multiple HPV infections were detected among 7.9 % of participants. Risk factors such as level of education (X 2 = 15.897; p = 0.007), age at sexual debut (X 2 = 6.916; p = 0.009), parity (X 2 = 23.767; p = 0.000), number of life time sexual partners (X 2 = 7.805; p = 0.005), age at first pregnancy (X 2 = 10.554; p = 0.005) and history of other malignancies (X 2 = 7.325; p = 0.007) were found to have a statistically significant association with HPV infection.

Conclusion

This study identified a high burden of HPV infection in Northern Nigeria while also confirming HPV 18 and 16 as the most predominant genotypes. It further justifies the potential benefit of the currently available HPV vaccines in the area. A larger and community based study is however recommended for better representation of the area.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. The Lancet. 2007;370:890–907.CrossRef Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. The Lancet. 2007;370:890–907.CrossRef
4.
go back to reference Wheeler CM, Castellsagué X, Garland SM, Szarewski A, Paavonen J, Naud P, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13:100–10.CrossRefPubMed Wheeler CM, Castellsagué X, Garland SM, Szarewski A, Paavonen J, Naud P, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13:100–10.CrossRefPubMed
5.
go back to reference Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis. 2010;10:862–74.CrossRefPubMed Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis. 2010;10:862–74.CrossRefPubMed
6.
go back to reference Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, et al. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies. Int J Cancer J Int Cancer. 2012;130:2111–7.CrossRef Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, et al. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies. Int J Cancer J Int Cancer. 2012;130:2111–7.CrossRef
7.
go back to reference Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16:41–9.CrossRefPubMed Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16:41–9.CrossRefPubMed
8.
go back to reference Awodele O, Adeyomoye AAA, Awodele DF, Kwashi V, Awodele IO, Dolapo DC. A Study on Cervical Cancer Screening Amongst Nurses in Lagos University Teaching Hospital, Lagos, Nigeria. J Cancer Educ. 2011;26:497–504.PubMedCentralCrossRefPubMed Awodele O, Adeyomoye AAA, Awodele DF, Kwashi V, Awodele IO, Dolapo DC. A Study on Cervical Cancer Screening Amongst Nurses in Lagos University Teaching Hospital, Lagos, Nigeria. J Cancer Educ. 2011;26:497–504.PubMedCentralCrossRefPubMed
10.
go back to reference Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer. 2004;90:638–45.PubMedCentralCrossRefPubMed Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer. 2004;90:638–45.PubMedCentralCrossRefPubMed
11.
go back to reference Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJ, et al. Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer. 2010;5:24.PubMedCentralCrossRefPubMed Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJ, et al. Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer. 2010;5:24.PubMedCentralCrossRefPubMed
13.
go back to reference Ajuwon AJ, Olaleye A, Faromoju B, Ladipo O. Sexual behavior and experience of sexual coercion among secondary school students in three states in North Eastern Nigeria. BMC Public Health. 2006;6:310.PubMedCentralCrossRefPubMed Ajuwon AJ, Olaleye A, Faromoju B, Ladipo O. Sexual behavior and experience of sexual coercion among secondary school students in three states in North Eastern Nigeria. BMC Public Health. 2006;6:310.PubMedCentralCrossRefPubMed
14.
go back to reference Kyari O, Nggada H, Mairiga A. Malignant tumours of female genital tract in North Eastern Nigeria. East Afr Med J. 2004;81:142–5.CrossRefPubMed Kyari O, Nggada H, Mairiga A. Malignant tumours of female genital tract in North Eastern Nigeria. East Afr Med J. 2004;81:142–5.CrossRefPubMed
15.
go back to reference Audu BM, Bukar M, Ibrahim AI, Swende TZ. Awareness and perception of human papilloma virus vaccine among healthcare professionals in Nigeria. J Obstet Gynaecol. 2014;34:714–7.CrossRefPubMed Audu BM, Bukar M, Ibrahim AI, Swende TZ. Awareness and perception of human papilloma virus vaccine among healthcare professionals in Nigeria. J Obstet Gynaecol. 2014;34:714–7.CrossRefPubMed
16.
go back to reference Evans MF, Adamson CS, Simmons-Arnold L, Cooper K. Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol. 2005;5:10.PubMedCentralCrossRefPubMed Evans MF, Adamson CS, Simmons-Arnold L, Cooper K. Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol. 2005;5:10.PubMedCentralCrossRefPubMed
17.
go back to reference Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, et al. Improved Amplification of Genital Human Papillomaviruses. J Clin Microbiol. 2000;38:357–61.PubMedCentralPubMed Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, et al. Improved Amplification of Genital Human Papillomaviruses. J Clin Microbiol. 2000;38:357–61.PubMedCentralPubMed
18.
go back to reference Auwal IK, Aminu M, Atanda AT, Tukur J, Sarkinfada F. Prevalence and Risk Factors of High Risk Human Papillomavirus Infections among Women Attending Gynaecology Clinics in Kano, Northern Nigeria. Bayero J Pure Appl Sci. 2014;6:67–71.CrossRef Auwal IK, Aminu M, Atanda AT, Tukur J, Sarkinfada F. Prevalence and Risk Factors of High Risk Human Papillomavirus Infections among Women Attending Gynaecology Clinics in Kano, Northern Nigeria. Bayero J Pure Appl Sci. 2014;6:67–71.CrossRef
19.
go back to reference Ezechi OC, Ostergren PO, Nwaokorie FO, Ujah IA, Pettersson KO. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Virol J. 2014;11:5.PubMedCentralCrossRefPubMed Ezechi OC, Ostergren PO, Nwaokorie FO, Ujah IA, Pettersson KO. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Virol J. 2014;11:5.PubMedCentralCrossRefPubMed
20.
go back to reference AdegbesanOmilabu M, Okunade K, Omilabu S. Oncogenic human papilloma virus infection among women attending the cytology clinic of a tertiary hospital in Lagos, South-West Nigeria. Int J Res Med Sci. 2014;2:625.CrossRef AdegbesanOmilabu M, Okunade K, Omilabu S. Oncogenic human papilloma virus infection among women attending the cytology clinic of a tertiary hospital in Lagos, South-West Nigeria. Int J Res Med Sci. 2014;2:625.CrossRef
21.
go back to reference Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, et al. HIV associated high-risk HPV infection among Nigerian women. BMC Infect Dis. 2013;13:521.PubMedCentralCrossRefPubMed Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, et al. HIV associated high-risk HPV infection among Nigerian women. BMC Infect Dis. 2013;13:521.PubMedCentralCrossRefPubMed
22.
go back to reference National Population Commission (NPC) [Nigeria] and ICF International. 2014. Nigeria Demographic and Health Survey 2013. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and ICF International. National Population Commission (NPC) [Nigeria] and ICF International. 2014. Nigeria Demographic and Health Survey 2013. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and ICF International.
23.
go back to reference Didelot-Rousseau M-N, Nagot N, Costes-Martineau V, Vallès X, Ouedraogo A, Konate I, et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer. 2006;95:355–62.PubMedCentralCrossRefPubMed Didelot-Rousseau M-N, Nagot N, Costes-Martineau V, Vallès X, Ouedraogo A, Konate I, et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer. 2006;95:355–62.PubMedCentralCrossRefPubMed
24.
go back to reference De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, et al. Distribution of Human Papillomavirus in a Family Planning Population in Nairobi, Kenya. Sex Transm Dis. 2003;30:137–42.CrossRefPubMed De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, et al. Distribution of Human Papillomavirus in a Family Planning Population in Nairobi, Kenya. Sex Transm Dis. 2003;30:137–42.CrossRefPubMed
25.
go back to reference Salih MM, Safi ME, Hart K, Tobi K, Adam I. Genotypes of human papilloma virus in Sudanese women with cervical pathology. Infect Agent Cancer. 2010;5:26.PubMedCentralCrossRefPubMed Salih MM, Safi ME, Hart K, Tobi K, Adam I. Genotypes of human papilloma virus in Sudanese women with cervical pathology. Infect Agent Cancer. 2010;5:26.PubMedCentralCrossRefPubMed
26.
go back to reference Zandi K, Eghbali SS, Hamkar R, Ahmadi S, Ramedani E, Deilami I, et al. Prevalence of various Human Papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (South west of Iran) 2008–2009. Virol J. 2010;7:65.PubMedCentralCrossRefPubMed Zandi K, Eghbali SS, Hamkar R, Ahmadi S, Ramedani E, Deilami I, et al. Prevalence of various Human Papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (South west of Iran) 2008–2009. Virol J. 2010;7:65.PubMedCentralCrossRefPubMed
27.
go back to reference Zhao F-H, Forman MR, Belinson J, Shen Y, Graubard BI, Patel AC, et al. Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China. Int J Cancer J Int Cancer. 2006;118:442–8.CrossRef Zhao F-H, Forman MR, Belinson J, Shen Y, Graubard BI, Patel AC, et al. Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China. Int J Cancer J Int Cancer. 2006;118:442–8.CrossRef
28.
go back to reference Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol. 1993;67:6424.PubMedCentralPubMed Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol. 1993;67:6424.PubMedCentralPubMed
29.
go back to reference Orozco-Colín A, Carrillo-García A, Méndez-Tenorio A, Ponce-de-León S, Mohar A, Maldonado-Rodríguez R, et al. Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology. Int J Infect Dis. 2010;14:e1082–7.CrossRefPubMed Orozco-Colín A, Carrillo-García A, Méndez-Tenorio A, Ponce-de-León S, Mohar A, Maldonado-Rodríguez R, et al. Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology. Int J Infect Dis. 2010;14:e1082–7.CrossRefPubMed
30.
go back to reference Bruni L, Diaz M, Castellsagué M, Ferrer E, Bosch FX, de Sanjosé S. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings. J Infect Dis. 2010;202:1789–99.CrossRefPubMed Bruni L, Diaz M, Castellsagué M, Ferrer E, Bosch FX, de Sanjosé S. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings. J Infect Dis. 2010;202:1789–99.CrossRefPubMed
31.
go back to reference Galloway DA. Is vaccination against human papillomavirus a possibility? Lancet. 1998;351 Suppl 3:22–4.CrossRefPubMed Galloway DA. Is vaccination against human papillomavirus a possibility? Lancet. 1998;351 Suppl 3:22–4.CrossRefPubMed
32.
go back to reference Li J, Cai H, Xu Z, Wang Q, Hang D, Shen N, et al. Nine Complete Genome Sequences of Cutaneous Human Papillomavirus Genotypes Isolated from Healthy Skin of Individuals Living in Rural He Nan Province, China. J Virol. 2012;86:11936–6. Li J, Cai H, Xu Z, Wang Q, Hang D, Shen N, et al. Nine Complete Genome Sequences of Cutaneous Human Papillomavirus Genotypes Isolated from Healthy Skin of Individuals Living in Rural He Nan Province, China. J Virol. 2012;86:11936–6.
33.
go back to reference Canuti M, Deijs M, Jazaeri Farsani SM, Holwerda M, Jebbink MF, de Vries M, et al. Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus. Virology. 2014;5:347. Canuti M, Deijs M, Jazaeri Farsani SM, Holwerda M, Jebbink MF, de Vries M, et al. Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus. Virology. 2014;5:347.
34.
go back to reference Carvalho Nde O, del Castillo DM, Perone C, Januário JN, Melo VH, Brasileiro Filho G. Comparison of HPV genotyping by type-specific PCR and sequencing. Mem Inst Oswaldo Cruz. 2010;105:73–8.CrossRefPubMed Carvalho Nde O, del Castillo DM, Perone C, Januário JN, Melo VH, Brasileiro Filho G. Comparison of HPV genotyping by type-specific PCR and sequencing. Mem Inst Oswaldo Cruz. 2010;105:73–8.CrossRefPubMed
35.
go back to reference Cai YP, Yang Y, Zhu BL, Li Y, Xia XY, Zhang RF, et al. Comparison of human papillomavirus detection and genotyping with four different prime sets by PCR-sequencing. Biomed Environ Sci BES. 2013;26:40–7.PubMed Cai YP, Yang Y, Zhu BL, Li Y, Xia XY, Zhang RF, et al. Comparison of human papillomavirus detection and genotyping with four different prime sets by PCR-sequencing. Biomed Environ Sci BES. 2013;26:40–7.PubMed
36.
go back to reference Giorgi Rossi P, Bisanzi S, Paganini I, Di Iasi A, Angeloni C, Scalisi A, et al. Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study. BMC Infect Dis. 2010;10:214.PubMedCentralPubMed Giorgi Rossi P, Bisanzi S, Paganini I, Di Iasi A, Angeloni C, Scalisi A, et al. Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study. BMC Infect Dis. 2010;10:214.PubMedCentralPubMed
37.
go back to reference Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine. 2008;26 Suppl 10:K17–28.PubMedCentralCrossRefPubMed Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine. 2008;26 Suppl 10:K17–28.PubMedCentralCrossRefPubMed
38.
go back to reference Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet. 2012;285:771–7.CrossRefPubMed Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet. 2012;285:771–7.CrossRefPubMed
39.
go back to reference Chang IJ, Huang R, He W, Zhang S-K, Wang S-M, Zhao F-H, et al. Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study. BMC Public Health. 2013;13:916.PubMedCentralCrossRefPubMed Chang IJ, Huang R, He W, Zhang S-K, Wang S-M, Zhao F-H, et al. Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study. BMC Public Health. 2013;13:916.PubMedCentralCrossRefPubMed
40.
go back to reference Rocha-Brischiliari SC, Gimenes F, de Abreu ALP, Irie MM, Souza RP, Santana RG, et al. Risk factors for cervical HPV infection and genotypes distribution in HIV-infected South Brazilian women. Infect Agent Cancer. 2014;9:6.PubMedCentralCrossRefPubMed Rocha-Brischiliari SC, Gimenes F, de Abreu ALP, Irie MM, Souza RP, Santana RG, et al. Risk factors for cervical HPV infection and genotypes distribution in HIV-infected South Brazilian women. Infect Agent Cancer. 2014;9:6.PubMedCentralCrossRefPubMed
41.
go back to reference Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev. 1997;6:799–805.PubMed Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev. 1997;6:799–805.PubMed
42.
go back to reference Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011;12:663–72.PubMedCentralCrossRefPubMed Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011;12:663–72.PubMedCentralCrossRefPubMed
Metadata
Title
Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria
Authors
Mohammed Mohammed Manga
Adeola Fowotade
Yusuf Mohammed Abdullahi
Aliyu Usman El-nafaty
Danladi Bojude Adamu
Hamidu Umar Pindiga
Rasheed Ajani Bakare
Abimbola Olu Osoba
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Infectious Agents and Cancer / Issue 1/2015
Electronic ISSN: 1750-9378
DOI
https://doi.org/10.1186/s13027-015-0035-8

Other articles of this Issue 1/2015

Infectious Agents and Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine